Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efavirenz Intensification for HIV-1 Reservoir Reduction
NCT07193875Phase 4Completed
- Sponsor
- Washington University School of Medicine
- Start
- Feb 2023
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of efavirenz in human immunodeficiency virus infection (HIV), sponsored by Washington University School of Medicine. Started Feb 2023; status: completed.
02
Drugs
efavirenz
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT07193875.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07193875.